Welcome to LookChem.com Sign In|Join Free
  • or
L-Glutamic acid, N-[4-[[(1,2,5,6-tetrahydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)sulfonyl] amino]benzoyl]-, diethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

139988-35-5

Post Buying Request

139988-35-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

139988-35-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 139988-35-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,9,9,8 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 139988-35:
(8*1)+(7*3)+(6*9)+(5*9)+(4*8)+(3*8)+(2*3)+(1*5)=195
195 % 10 = 5
So 139988-35-5 is a valid CAS Registry Number.

139988-35-5Relevant academic research and scientific papers

Combination of benzoquinazoline antifolates and protecting agents

-

, (2008/06/13)

The use of a protecting agent, for example a folate derivative such as folic acid or leucovorin, in combination with a non-competitive folic acid analogue, for example benzoquinazoline derivatives, for use in reducing the side effects associated with the

Pharmaceutically active benzoquinazoline compounds

-

Example 28, (2010/11/29)

Compounds of formula (I) or salts thereof, wherein the dotted line represents a single or double bond, R1is alkyl or amino optionally substituted by alkyl, alkanoyl or benzyl group; R2, R3, R4and R5are the same or different and each is selected from hydrogen, phenyl, halo, nitro, a group S(O)nR8wherein n is the integer 0, 1 or 2 and R8is halo or alkyl or a group NR9R10wherein R9and R10are both hydrogen, a group NR11R12wherein R11and R12are the same or different and each is hydrogen or alkyl, a group OR13wherein R13is hydrogen or C1-4alkyl optionally substituted by halo; a C1-4aliphatic group optionally substituted by a group OR14or NR14R15wherein R14and R15are the same or different and each is hydrogen or alkyl; or two of R2to R5are linked together to form a benzo group, or one of R2to R5is a group -X-Y-R16wherein X is CH2, NR17, CO or S(O)m, and Y is CH2, NR17, O, or S(O)m, or -X-Y- is a group -O-, -NR17-, -CH=CH- or -N=N-, are disclosed as pharmacological agents useful in the treatment of tumours. Pharmaceutical compositions and methods for the preparation of compounds of formula (I) are also described.

PHARMACEUTICAL COMPOUNDS

-

, (2008/06/13)

The present invention relates to novel benzoquinazoline thymidylate synthase inhibitors, to pharmaceutical formulations containing them and to their use in medicine

Benzoquinazoline Inhibitors of Thymidylate Synthase: Enzyme Inhibitory Activity and Cytotoxicity of Some Sulfonamidobenzoylglutamate and Related Derivatives

Pendergast, William,Dickerson, Scott H.,Johnson, Jay V.,Dev, Inderjit K.,Ferone, Robert,et al.

, p. 3464 - 3471 (2007/10/02)

Several folate-like thymidylate synthase inhibitors are described in which the pteridine nucleus of the folic acid molecule is replaced by a benzoquinazoline moiety, which in turn is attached to the benzoylglutamate side chain by a sulfonamide link.The mo

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 139988-35-5